AchalasiaNCT02055469
Achalasia: Mechanisms Underlying Treatment Failure
An observational study of Achalasia, run by Barts & The London NHS Trust at 1 site in United Kingdom.
Trial summary
In patients with achalasia, the relationship between the perception of dysphagia, oesophageal emptying, lower oesophageal sphincter (LOS) distensibility and oesophageal circular and longitudinal muscle contraction is not clear. Read more about this study
- Who is it for?
- Ages 18 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Achalasia
- How many people
- 40 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Mar 2014to Mar 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients with achalasia (or suspected achalasia) either before or after treatment referred from secondary care to the GI physiology unit of the Royal London Hospital
Who may be able to join
- Patients with achalasia diagnosed on HRM criteria, with or without previous treatment
- Written ICF signed voluntarily before the first trial-related activity.
- Male or female, aged 18-70
- If the subject is a woman of childbearing potential, she must have a negative urine pregnancy test before the start of assessments
Who cannot join
- Any abnormal oesophageal motility finding that is not consistent with achalasia
- History of gastrointestinal tract surgery, fundoplication, endoscopic anti reflux procedure or any other recent abdominal operation in the last 6 months
- Major psychiatric, neurological, respiratory, liver, haemorrhagic and cardiac disorders, malignancies
- Pregnancy
- Subjects with a documented history of long segment (>3 cm) Barrett's oesophagus, large (> 3 cm) hiatus hernia, structural abnormalities of oesophagus (i.e. Rings, webs, scleroderma)
- Use of prokinetic medication less than 7 days before the start of the study
- Any condition that in the opinion of the Investigator would complicate or compromise the trial or the well-being of the subject.
- Evidence of any clinically relevant pathology that could interfere with trial results or put subject safety at risk.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Achalasia; Mechanisms Underlying Persistent Symptoms After Treatment
In patients with achalasia, the relationship between the perception of dysphagia, oesophageal emptying, lower oesophageal sphincter (LOS) distensibility and oesophageal circular and longitudinal muscle contraction is not clear.
We aim to characterize oesophageal circumferential and longitudinal muscle contractility and LOS distensibility in patients with achalasia (either before or after treatment). This may allow an understanding of the mechanisms underlying persistent dysphagia and delayed oesophageal emptying after treatment.
Read the detailed description
This is observational study of patients with achalasia (with or without treatment). Treatment will have been a previous Heller's myotomy or pneumatic dilatation (and is not randomised). Patients with known or suspected achalasia will attend the GI physiology unit at the Royal London Hospital for standard care. Standard care involves assessing the perception of dysphagia with questionnaires, assessing oesophageal circular muscle function with high resolution oesophageal manometry (HRM) and oesophageal emptying with a timed barium oesophagram (TBO). The two experimental tests performed as part of the study (which are not currently routine care) are EndoFLIP and HFIUS.
On arrival at the GI physiology unit, patients will be given verbal and written information about the study (including standard care and non-standard tests). They will then be asked if they wish to participate. Informed written consent will be obtained.
Participants will complete questionnaires and HRM. If HRM is not consistent with achalasia, the patient's participation in the study ends. If HRM is consistent with achalasia then the participant will then undergo EndoFLIP, HFIUS and TBO.
Assessments are as follows (but are not necessarily done in the order given:
- Perception of dysphagia (using MAYO and Eckardt questionnaires)
Dysphagia questionnaires are a non-intrusive, quick and well validated method of assessing the perception of dysphagia and are considered part of standard care.
- Oesophageal circular muscle function (using HRM)
HRM is part of standard care and is performed in the GI physiology unit routinely by appropriately trained and experienced investigators. It involves the insertion of a small catheter into the oesophagus via the transnasal route. The only risk to the patient is nasopharyngeal discomfort on insertion, which is reduced by the use of nasal lignocaine spray. Ten 5ml water swallows are assessed and the duration is typically 10 to 15 minutes.
- Oesophageal emptying (using TBO)
TBO is a standard/routine investigation in assessing suspected or treated achalasia. It is a variant of a "barium swallow". The patient drinks 200mls of barium and has plain radiological films taken at 1,3 and 5 minutes. The TBO is performed in the GI physiology unit by investigators with appropriate training and certification (IRMER). It involves the use of ionising radiation (X rays) but is not an experimental procedure.
- Distensibility of the mid oesophagus and LOS (using EndoFLIP)
Endoscopic functional luminal imaging probe (EndoFLIP) is not part of standard care. It is very similar to HRM as it uses a small catheter which is inserted into the oesophagus via the transnasal route. There is a small water filled balloon at the tip of the catheter which is gently inflated using water. The distensibility of any part of the oesophagus is thus able to be measured. Like HRM the only risk to the participant is nasopharyngeal discomfort on insertion. The duration of the procedure is 10 to 15 minutes.
- Longitudinal muscle thickness and contraction (using HFIUS)
High frequency intra luminal ultrasound (HFIUS) is not part of standard care and will be performed in the endoscopy unit of the Royal London Hospital (which is located very close to the GI physiology unit). Like HRM and EndoFLIP, it uses a small catheter which is inserted into the oesophagus via the transnasal route. It is able to visualise the layers of the oesophageal wall. Again, the only risk to the patient is discomfort. The procedure takes about 10 to 15 minutes.
Patients with achalasia will classified on TBO as having either normal or delayed oesophageal emptying. The perception of dysphagia and motility characteristics of these two groups will then be compared using an independent samples t test. SPSS will be used for statistical analysis. An independent statistician has reviewed and approved the protocol.
- Conditions
- Achalasia
- Keywords
- Achalasia
- Medical subject headings
- Esophageal Achalasia
What is being measured
The primary outcome is the main question the study is designed to answer.
Perception of dysphagia
Questionnaires
Measured: Baseline (At recruitment )
Oesophageal circumferential muscle contractility
Using high resolution oesophageal manometry
Measured: Baseline (At recruitment )
Oesophageal longitudinal muscle contraction
High frequency intraluminal oesophageal ultrasound
Measured: Baseline (At recruitment )
Oesophageal emptying
Timed barium oesophagram
Measured: Baseline (At recruitment )
Assessment of oesophageal and LOS distensibility
Using endoscopic functional luminal imaging probe (EndoFLIP)
Measured: Baseline (At recruitment )
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2014 (estimated)
- Study startMar 2014
- Primary completionMar 2015
- Study completionMar 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AchalasiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Barts & The London NHS Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02055469
- Sponsor's protocol ID
- 009393
- Status last verified
- Sep 2023
- First submitted
- 4 Feb 2014
- Last updated
- 8 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Achalasia; Mechanisms Underlying Persistent Symptoms After Treatment
- ClinicalTrials.gov ID
- NCT02055469
- Acronym / sponsor ID
- 009393
- Conditions
- Achalasia
- Keywords
- Achalasia
- Study type
- Observational
- Recruitment status
- Terminated
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Barts & The London NHS TrustUniversity, hospital or other
- Study start
- Mar 2014 (actual)
- Primary completion
- Mar 2015 (actual)
- Study completion
- Mar 2015 (actual)
- First posted
- 5 Feb 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In patients with achalasia, the relationship between the perception of dysphagia, oesophageal emptying, lower oesophageal sphincter (LOS) distensibility and oesophageal circular and longitudinal muscle contraction is not clear.
We aim to characterize oesophageal circumferential and longitudinal muscle contractility and LOS distensibility in patients with achalasia (either before or after treatment). This may allow an understanding of the mechanisms underlying persistent dysphagia and delayed oesophageal emptying after treatment.
Detailed description
This is observational study of patients with achalasia (with or without treatment). Treatment will have been a previous Heller's myotomy or pneumatic dilatation (and is not randomised). Patients with known or suspected achalasia will attend the GI physiology unit at the Royal London Hospital for standard care. Standard care involves assessing the perception of dysphagia with questionnaires, assessing oesophageal circular muscle function with high resolution oesophageal manometry (HRM) and oesophageal emptying with a timed barium oesophagram (TBO). The two experimental tests performed as part of the study (which are not currently routine care) are EndoFLIP and HFIUS.
On arrival at the GI physiology unit, patients will be given verbal and written information about the study (including standard care and non-standard tests). They will then be asked if they wish to participate. Informed written consent will be obtained.
Participants will complete questionnaires and HRM. If HRM is not consistent with achalasia, the patient's participation in the study ends. If HRM is consistent with achalasia then the participant will then undergo EndoFLIP, HFIUS and TBO.
Assessments are as follows (but are not necessarily done in the order given:
- Perception of dysphagia (using MAYO and Eckardt questionnaires)
Dysphagia questionnaires are a non-intrusive, quick and well validated method of assessing the perception of dysphagia and are considered part of standard care.
- Oesophageal circular muscle function (using HRM)
HRM is part of standard care and is performed in the GI physiology unit routinely by appropriately trained and experienced investigators. It involves the insertion of a small catheter into the oesophagus via the transnasal route. The only risk to the patient is nasopharyngeal discomfort on insertion, which is reduced by the use of nasal lignocaine spray. Ten 5ml water swallows are assessed and the duration is typically 10 to 15 minutes.
- Oesophageal emptying (using TBO)
TBO is a standard/routine investigation in assessing suspected or treated achalasia. It is a variant of a "barium swallow". The patient drinks 200mls of barium and has plain radiological films taken at 1,3 and 5 minutes. The TBO is performed in the GI physiology unit by investigators with appropriate training and certification (IRMER). It involves the use of ionising radiation (X rays) but is not an experimental procedure.
- Distensibility of the mid oesophagus and LOS (using EndoFLIP)
Endoscopic functional luminal imaging probe (EndoFLIP) is not part of standard care. It is very similar to HRM as it uses a small catheter which is inserted into the oesophagus via the transnasal route. There is a small water filled balloon at the tip of the catheter which is gently inflated using water. The distensibility of any part of the oesophagus is thus able to be measured. Like HRM the only risk to the participant is nasopharyngeal discomfort on insertion. The duration of the procedure is 10 to 15 minutes.
- Longitudinal muscle thickness and contraction (using HFIUS)
High frequency intra luminal ultrasound (HFIUS) is not part of standard care and will be performed in the endoscopy unit of the Royal London Hospital (which is located very close to the GI physiology unit). Like HRM and EndoFLIP, it uses a small catheter which is inserted into the oesophagus via the transnasal route. It is able to visualise the layers of the oesophageal wall. Again, the only risk to the patient is discomfort. The procedure takes about 10 to 15 minutes.
Patients with achalasia will classified on TBO as having either normal or delayed oesophageal emptying. The perception of dysphagia and motility characteristics of these two groups will then be compared using an independent samples t test. SPSS will be used for statistical analysis. An independent statistician has reviewed and approved the protocol.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with achalasia (or suspected achalasia) either before or after treatment referred from secondary care to the GI physiology unit of the Royal London Hospital
Key inclusion criteria (4 listed)
- Patients with achalasia diagnosed on HRM criteria, with or without previous treatment
- Written ICF signed voluntarily before the first trial-related activity.
- Male or female, aged 18-70
- If the subject is a woman of childbearing potential, she must have a negative urine pregnancy test before the start of assessments
Key exclusion criteria (8 listed)
- Any abnormal oesophageal motility finding that is not consistent with achalasia
- History of gastrointestinal tract surgery, fundoplication, endoscopic anti reflux procedure or any other recent abdominal operation in the last 6 months
- Major psychiatric, neurological, respiratory, liver, haemorrhagic and cardiac disorders, malignancies
- Pregnancy
- Subjects with a documented history of long segment (>3 cm) Barrett's oesophagus, large (> 3 cm) hiatus hernia, structural abnormalities of oesophagus (i.e. Rings, webs, scleroderma)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Perception of dysphagia
Time frame: Baseline (At recruitment )
Questionnaires
Oesophageal circumferential muscle contractility
Time frame: Baseline (At recruitment )
Using high resolution oesophageal manometry
Oesophageal longitudinal muscle contraction
Time frame: Baseline (At recruitment )
High frequency intraluminal oesophageal ultrasound
Oesophageal emptying
Time frame: Baseline (At recruitment )
Timed barium oesophagram
Assessment of oesophageal and LOS distensibility
Time frame: Baseline (At recruitment )
Using endoscopic functional luminal imaging probe (EndoFLIP)
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2023.
Related trials for Achalasia
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingPhase 2
Full-thickness Versus Progressive Myotomy in Peroral Endoscopic Esophageal Myotomy in Achalasia: A Randomized Controlled Trial
Achalasia Cardia, Achalasia
RecruitingPhase 3
PREcision MEDicine In Achalasia (PREMEDIA)
Type I Achalasia, Type II Achalasia
RecruitingObservational study
PREcision MEDicine In Achalasia (PREMEDIA) - Cohort
Type III Achalasia, EGJ Outflow Obstruction With Spastic/Hypercontractile Features
RecruitingPhase 4
VZV in the Enteric Nervous System: Pathogenesis and Consequences
Achalasia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Achalasia, run by Barts & The London NHS Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 8 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Perception of dysphagia (time frame: Baseline (At recruitment )). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2023.